Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Fallucco

Plastic Surgery Within the Head and Neck Jacksonville, FL Medical Doctor

NPI 1851594436 CMS profile 39431

14540 Old Saint Augustine Rd, Suite 2391, Jacksonville, FL 32258

Open in the dashboard

General payments

$36,692

146 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$100,000

1 holding reported · through program year 2025

Through program year 2025, Michael Fallucco of Jacksonville, FL is reported in the CMS Open Payments database as having received $36,692 across 146 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $100,000 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Plastic Surgery Within the Head and Neck profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,351 33
2024 General $524 13
2023 General $1,222 21
2022 General $23,196 35
2021 General $403 17
2020 General $9,601 14
2019 General $395 13
2025 Ownership $100,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Fallucco
  • Plastic Surgery Within the Head and Neck median
  • Middle half of Plastic Surgery Within the Head and Neck
  • National median

In program year 2025, general payments to Michael Fallucco were reported at $1,351. Among 103 Plastic Surgery Within the Head and Neck profiles paid that year, the median was $300 and the middle half received between $115 and $580.

Show as a table
Year Michael Fallucco Plastic Surgery Within the Head and Neck median Middle half National median
2019 $395 $270 $76–$780 $163
2020 $9,601 $172 $52–$421 $114
2021 $403 $227 $64–$753 $132
2022 $23,196 $338 $112–$800 $149
2023 $1,222 $303 $89–$723 $160
2024 $524 $289 $115–$714 $164
2025 $1,351 $300 $115–$580 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Surgical Innovation Associates, Inc. $22,046 8 payments
  2. Baxter Healthcare $9,440 5 payments
  3. Musculoskeletal Transplant Foundation Inc. $1,562 14 payments
  4. Mentor Worldwide LLC $981 33 payments
  5. Allergan Inc. $525 13 payments
  6. TELA Bio, Inc. $451 13 payments
  7. AbbVie, Inc. $437 14 payments
  8. Sientra, Inc. $149 3 payments
  9. W. L. Gore & Associates, Inc. $110 6 payments
  10. Access Pro Medical, LLC $105 1 payment
  11. Other $885 36 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Long term medical supply or device loan $22,046 8 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,265 1 payment
  3. Food and Beverage $4,994 132 payments
  4. Consulting Fee $1,140 2 payments
  5. Travel and Lodging $147 1 payment
  6. Grant $100 2 payments
Products named General payments · program years 2019–2025
  1. DuraSorb Monofilament Mesh $22,046 8 payments
  2. No Related Product $9,417 4 payments
  3. MENTOR MemoryGel Resterilizable Gel Sizer $641 18 payments
  4. ARTOURA Breast Tissue Expander Plastic Surgery $485 14 payments
  5. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $427 12 payments
  6. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $330 8 payments
  7. ARTOURA Breast Tissue Expander Plastic Surgery $206 8 payments
  8. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $193 6 payments
  9. MemoryGel Breast Implants $193 6 payments
  10. NATRELLE $158 2 payments
  11. Other $1,603 60 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

458

Median for Plastic and Reconstructive Surgery: 61

Drug cost

$5,903

Median for Plastic and Reconstructive Surgery: $369

Branded share of claims

31.9%

Median for Plastic and Reconstructive Surgery: 30%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 11 $2,963
Cefuroxime Cefuroxime Axetil Brand 61 $859
Mupirocin Generic 99 $740
Ondansetron Odt Ondansetron Brand 74 $648
Cyclobenzaprine Hcl Generic 62 $249
Ibuprofen Generic 66 $212
Gabapentin Generic 72 $181
Methocarbamol Generic 13 $50

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,638 Part D prescribers listed as Plastic and Reconstructive Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$46,989

Medicare's payments for the services billed

Medicare patients

62

Average age 71

Services billed

168

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Cancer 68%
Arthritis 53%
Diabetes 37%
Depression 29%
Ischemic heart disease 26%
Chronic kidney disease 26%
Heart failure 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Exparel
  • Pacira Pharmaceuticals Incorporated $19
$19 — —
BOTOX
  • AbbVie, Inc. $16
$16 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

146 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery Within the Head and Neck in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record